Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Synpart AG is a Swiss-based company specializing in the sourcing, distribution, and logistics of active pharmaceutical ingredients (APIs), excipients, and chemical intermediates for the global pharmaceutical and life sciences industries. Founded in 2004 and headquartered in Baar, the company acts as a strategic partner for pharmaceutical manufacturers, providing regulatory support, quality assurance, and efficient supply chain management. Synpart facilitates the procurement of high-quality materials from a global network of suppliers, particularly bridging the gap between Asian manufacturers and European markets. In addition to distribution, the company offers custom synthesis services to meet specific client requirements for specialized chemical compounds. The company maintains a strong focus on compliance with international quality standards, including GMP and GDP, ensuring the integrity of the pharmaceutical supply chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Synpart.